Becton Dickinson Revenue 2010-2023 | BDX

Becton Dickinson annual/quarterly revenue history and growth rate from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Becton Dickinson revenue for the quarter ending December 31, 2023 was $4.706B, a 2.62% increase year-over-year.
  • Becton Dickinson revenue for the twelve months ending December 31, 2023 was $19.492B, a 4.02% increase year-over-year.
  • Becton Dickinson annual revenue for 2023 was $19.372B, a 2.66% increase from 2022.
  • Becton Dickinson annual revenue for 2022 was $18.87B, a 1.36% decline from 2021.
  • Becton Dickinson annual revenue for 2021 was $19.131B, a 19.02% increase from 2020.
Becton Dickinson Annual Revenue
(Millions of US $)
2023 $19,372
2022 $18,870
2021 $19,131
2020 $16,074
2019 $17,290
2018 $15,983
2017 $12,093
2016 $12,483
2015 $10,282
2014 $8,446
2013 $8,054
2012 $7,708
2011 $7,584
2010 $7,124
2009 $6,987
Becton Dickinson Quarterly Revenue
(Millions of US $)
2023-12-31 $4,706
2023-09-30 $5,087
2023-06-30 $4,878
2023-03-31 $4,821
2022-12-31 $4,586
2022-09-30 $4,761
2022-06-30 $4,641
2022-03-31 $4,750
2021-12-31 $4,718
2021-09-30 $4,302
2021-06-30 $4,607
2021-03-31 $4,907
2020-12-31 $5,315
2020-09-30 $3,741
2020-06-30 $3,855
2020-03-31 $4,253
2019-12-31 $4,225
2019-09-30 $4,585
2019-06-30 $4,350
2019-03-31 $4,195
2018-12-31 $4,160
2018-09-30 $4,403
2018-06-30 $4,278
2018-03-31 $4,222
2017-12-31 $3,080
2017-09-30 $3,167
2017-06-30 $3,035
2017-03-31 $2,969
2016-12-31 $2,922
2016-09-30 $3,232
2016-06-30 $3,198
2016-03-31 $3,067
2015-12-31 $2,986
2015-09-30 $3,060
2015-06-30 $3,120
2015-03-31 $2,051
2014-12-31 $2,051
2014-09-30 $2,202
2014-06-30 $2,157
2014-03-31 $2,072
2013-12-31 $2,015
2013-09-30 $2,101
2013-06-30 $2,053
2013-03-31 $2,000
2012-12-31 $1,900
2012-09-30 $1,967
2012-06-30 $1,981
2012-03-31 $1,929
2011-12-31 $1,832
2011-09-30 $1,868
2011-06-30 $1,952
2011-03-31 $1,922
2010-12-31 $1,842
2010-09-30 $1,625
2010-06-30 $1,831
2010-03-31 $1,799
2009-12-31 $1,869
2009-09-30 $1,724
2009-06-30 $1,820
2009-03-31 $1,725
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $69.833B $19.372B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $68.227B 18.26
Cardinal Health (CAH) United States $26.821B 16.12
West Pharmaceutical Services (WST) United States $26.629B 44.96
Align Technology (ALGN) United States $23.807B 47.17
Cooper (COO) United States $18.781B 29.53
Labcorp (LH) United States $18.293B 15.48
Henry Schein (HSIC) United States $10.469B 15.95
DENTSPLY SIRONA (XRAY) United States $7.138B 18.21
Merit Medical Systems (MMSI) United States $4.607B 26.68
Patterson (PDCO) United States $2.683B 12.27
CONMED (CNMD) United States $2.463B 23.21
STAAR Surgical (STAA) United States $1.550B 48.85
Atrion (ATRI) United States $0.623B 29.29
Lifevantage (LFVN) United States $0.090B 14.54
Pro-Dex (PDEX) United States $0.060B 22.67
Biolase (BIOL) United States $0.003B 0.00